Brandon Capital Australasia Fund 6

About Brandon Capital Australasia Fund 6

Life Sciences, HealthTech, MedTech focused fund

Investment Focus

Location / RegionAustralia

Funding StageGrowth

Industry Focus

Biotech

Digital Health

Med Tech

Investor Signals Profile

active

Sweet Spot

ANZ medtech/life sciences founders with clinical proof

medtech

oncology

life sciences

Australia/ANZ

breast cancer / surgical precision

Bullish Signals

Portfolio co presenting at RACS 2026external

Active medtech portfolio engagementexternal

OncoRes CMO keynote — RACS Perthlinkedin

Portfolio active in breast cancer trialslinkedin

Brandon Capital amplifying OncoRes RACS sessionslinkedin

Portfolio CMO: dual RACS keynote slotslinkedin

Portfolio CMO: gendered lens surgical carelinkedin

Contrarian Signals

Narrow sector focus — healthcare onlyexternal

Founder Do's

Build in medtech or life sciences

Show clinical validation or trials

Target ANZ or Asia-Pacific market

Engage clinical leaders / KOLs

Link to translational research

Founder Don'ts

Avoid non-healthcare sectors

Don't skip clinical evidence

No consumer or SaaS pitches

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund SizeA$439M+

Saves0

Website

Key People

Dr. Chris Nave, Chris Smith, Melissa McBurnie